Abstract
Conclusions
In 7 of 25 human subjects with acute leukemia treated with the folic acid antagonist 4-aminopteroylglutamic acid (aminopterin) morphologic changes developed in the circulating red blood cells consisting of a macrocytosis and anisocytosis.
Get full access to this article
View all access options for this article.